A Mayo Clinic study found that African Americans, specifically Somali Americans, exhibit significantly higher antibody responses to the rubella vaccine compared to Caucasians. This finding supports the concept of personalized medicine, suggesting that standard vaccine dosages may not be appropriate for all ethnic groups. The lack of peer-reviewed media coverage on these biological differences is criticized as a form of systemic oversight.
